DAY 2 - Monday, May 5
KEYNOTE ADDRESS
Curiosity drives award-winning research
Researchers should continue to explore offhand leads or spur-of-the-moment ideas, said 2005 Nobel laureate Barry Marshall, FRACP, FRS, FAA. It is those very actions that have sometimes led to world-changing, award-winning research, he explained. » MORE
|
|
DRUG THERAPY
Retinal inflammation: Novel drug delivery
Nanomedicine that targets activated microglia and neuro-inflammation may one day be a potential therapy for age-related macular degeneration (AMD), diabetic retinopathy, and other eye diseases, said Rangaramanujam Kannan, PhD. » MORE
|
|
Predictors for the number of AMD injections
Retinal angiomatous proliferation lesions, treatment with ranibizumab, the absence of subretinal fluid, and the absence of subretinal pigment epithelium fluid were associated with fewer injections for neovascular age-related macular degeneration (AMD) among participants from the Comparison of AMD Treatments Trials, said Daniel F. Martin, MD. » MORE
|
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
| |
|
 Top Tweets
|
|
We welcome your feedback!
Please send your comments to:
Mark L. Dlugoss
Group Content Director
Advanstar Eye Health Group
mdlugoss@advanstar.com |
|
|
